Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia.
J Clin Lipidol. 2022 Sep-Oct;16(5):617-625. doi: 10.1016/j.jacl.2022.06.005. Epub 2022 Jun 23.
J Clin Lipidol. 2022.
PMID: 35902351
Free article.
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk.
Tardif JC, Karwatowska-Prokopczuk E, Amour ES, Ballantyne CM, Shapiro MD, Moriarty PM, Baum SJ, Hurh E, Bartlett VJ, Kingsbury J, Figueroa AL, Alexander VJ, Tami J, Witztum JL, Geary RS, O'Dea LSL, Tsimikas S, Gaudet D.
Tardif JC, et al. Among authors: amour es.
Eur Heart J. 2022 Apr 6;43(14):1401-1412. doi: 10.1093/eurheartj/ehab820.
Eur Heart J. 2022.
PMID: 35025993
Free PMC article.
Clinical Trial.
Item in Clipboard
Management of High Hepatopulmonary Shunts in the Setting of Y90 Radioembolization.
Schiro BJ, Amour ES, Harnain C, Gandhi RT.
Schiro BJ, et al. Among authors: amour es.
Tech Vasc Interv Radiol. 2019 Jun;22(2):58-62. doi: 10.1053/j.tvir.2019.02.004. Epub 2019 Feb 27.
Tech Vasc Interv Radiol. 2019.
PMID: 31079711
Item in Clipboard
Cite
Cite